Faron’s Financial Calendar for 2025
Faron announces financial reporting calendar for 2025 with full-year results on 27 February and half-year results on 27 August.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the following dates for the Company's financial reporting in 2025:
| February 27 | Financial statement release for the full year 2024 and Annual Report 2024 including financial statements for the full year |
| August 2 7 | Half-year financial report for the period January 1 to June 30, 2025 |
The Annual General Meeting is planned to be held on March 21, 2025. A separate stock exchange notice will be issued by Faron's Board of Directors to convene the meeting.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.